REGENERATIVE BIO

regenerative-bio-logo

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing, Regenerative Bio combines AI pharmaceutical-related technologies with biology to explore ingredients, formulations and therapies with anti-aging effects, and solve the problems caused by aging.

#SimilarOrganizations #Financial #Website #More

REGENERATIVE BIO

Social Links:

Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical

Founded:
2020-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.regen-bio.us

Total Employee:
11+

Status:
Active

Total Funding:
10 M USD


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

helixnano-logo

HelixNano

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

Investors List

uphonest-capital_image

UpHonest Capital

UpHonest Capital investment in Angel Round - Regenerative Bio

taihill-venture_image

Taihill Venture

Taihill Venture investment in Angel Round - Regenerative Bio

k2-vc_image

K2VC

K2VC investment in Angel Round - Regenerative Bio

morningsidevc_image

5Y Capital

5Y Capital investment in Angel Round - Regenerative Bio

immersion-ventures_image

IMO Ventures

IMO Ventures investment in Angel Round - Regenerative Bio

yael-capital-management-limited_image

Yael Capital Management Limited

Yael Capital Management Limited investment in Angel Round - Regenerative Bio

Official Site Inspections

http://www.regen-bio.us

  • Host name: 46-197-245-216.static.reverse.lstn.net
  • IP address: 216.245.197.46
  • Location: Dallas United States
  • Latitude: 32.7767
  • Longitude: -96.805
  • Metro Code: 623
  • Timezone: America/Chicago
  • Postal: 75202

Loading ...

More informations about "Regenerative Bio"

Checkpoint Inhibitors and Cancer Vaccines | Regen BioPharma, Inc.

Regen BioPharma, Inc. is developing CAR-T cells and cancer vaccines using DNA and RNA technologies to target immune checkpoints.See details»

Investor Relations | Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTC PINK: RGBP) and (OTC PINK: RGBPP). The Company plans to rapidly advance novel technologies through pre โ€ฆSee details»

Regen BioPharma - Crunchbase Company Profile & Funding

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company โ€ฆSee details»

Regenerative Bio - Crunchbase Company Profile

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.See details»

Leadership Team - REGENXBIO

Curran M. Simpson is the President and Chief Executive Officer and member of the Board of Directors at REGENXBIO. Mr. Simpson previously served as the Companyโ€™s Chief Operating Officer.See details»

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

Nov 14, 2023ย ยท Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. โ€ฆSee details»

Who We Are - REGENXBIO

We are currently developing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. Our product candidates all utilize AAV viral โ€ฆSee details»

A new way to treat disease is on the horizon.

We are developing gene therapy product candidates in the retinal, metabolic and neurodegenerative therapeutic areas. We believe that what we do matters โ€“ to patients, to their families and to their communities. We set a high bar for โ€ฆSee details»

Regen BioPharma Company Profile - Office Locations, Competitors โ€ฆ

Oct 29, 2024ย ยท Regen BioPharma is a biotech company focused on the immunology and immunotherapy space. It is engaged in the development of small molecule therapies for โ€ฆSee details»

Board of Directors - REGENXBIO

Most recently, Dr. Karabelas has chaired the boards of several biopharmaceutical companies, including Human Genome Sciences, Inc., Vanda Pharmaceuticals, Inc., SkyePharma PLC and โ€ฆSee details»

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

Nov 14, 2023ย ยท Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. โ€ฆSee details»

Regen BioPharma, Inc. Selects Contract Research Organization to โ€ฆ

Nov 16, 2023ย ยท Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has announced the selection of a Contract Research Organization (CRO) to conduct in vitro studies on the โ€ฆSee details»

Regen BioPharma, Inc. to Discuss Plans to Move Forward with ...

Regen BioPharma, Inc. invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.See details»

Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

Oct 10, 2023ย ยท Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is โ€ฆSee details»

Regen BioPharma, Inc. to Initiate Development of its Modified โ€ฆ

SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is embarking on a development program to commercialize its modified mRNA anti โ€ฆSee details»

Regen BioPharma Advances FDA-Cleared Bone Marrow Therapy to โ€ฆ

Nov 19, 2024ย ยท Regen BioPharma (RGBP) has provided updates on its planned Phase 1 clinical trial for HemaXellerateโ„ข, a stem cell-derived therapy that received FDA clearance. The โ€ฆSee details»

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to ...

SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is currently completing a strategic analysis of its next 5 years of growth.See details»

Regen BioPharma Leverages Exosome Technologies to Broaden its โ€ฆ

SAN DIEGO, Jan. 20, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline โ€ฆSee details»

Patients & Families - REGENXBIO

REGENXBIO is committed to developing gene therapies that improve treatment options for people with serious diseases. The personal stories of patients and families help guide our โ€ฆSee details»

What is Regenerative Biology?

The field of regenerative biology aims to elucidate how organisms repair and replace missing cells, tissues and structures. It encompasses aspects of stem cell biology, wound healing, โ€ฆSee details»

linkstock.net © 2022. All rights reserved